Fuqiang Cui Selected Research

Fuqiang Cui Research Topics

Disease

30	Hepatitis B 06/2023 - 07/2009
21	Infections 10/2023 - 10/2012
6	COVID-19 10/2023 - 10/2020
6	Chronic Hepatitis B 06/2023 - 09/2015
4	Hepatitis A (Hepatitis, Infectious) 09/2023 - 01/2009
4	Human Influenza (Influenza) 01/2023 - 01/2021
3	Fibrosis (Cirrhosis) 10/2023 - 07/2019
3	Poliomyelitis (Polio) 01/2023 - 01/2022
3	Fever (Fevers) 03/2022 - 01/2014
2	Pneumonia (Pneumonitis) 04/2024 - 01/2022
2	Pain (Aches) 10/2023 - 03/2022
2	Neoplasms (Cancer) 10/2023 - 01/2021
2	Whooping Cough (Pertussis) 01/2023 - 03/2022
2	Tetanus 01/2023 - 03/2022
2	Hepatitis 10/2022 - 01/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2024
1	Coinfection 03/2024
1	Vaccine-Preventable Diseases 02/2024
1	Meningococcal Meningitis 11/2023
1	Dyspnea (Shortness of Breath) 10/2023
1	Mental Fatigue 10/2023
1	Hepatocellular Carcinoma (Hepatoma) 10/2023
1	Reinfection 09/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Hepatitis C 01/2023
1	Diphtheria 01/2023
1	Dehydration (Water Stress) 11/2022
1	Malaria 07/2022
1	Thrombosis (Thrombus) 04/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Febrile Seizures (Febrile Seizure) 01/2022
1	Diabetes Mellitus 10/2021
1	Congenital Abnormalities (Deformity) 03/2020
1	Disease Progression 07/2019
1	Virus Diseases (Viral Diseases) 01/2017
1	Infant Death 01/2016
1	Exanthema (Rash) 01/2014
1	Branchiootic syndrome 11/2013
1	Wounds and Injuries (Trauma) 11/2013

Drug/Important Bio-Agent (IBA)

25	VaccinesIBA 04/2024 - 01/2009
20	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2023 - 07/2009
11	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2022 - 12/2013
7	Antiviral Agents (Antivirals)IBA 06/2023 - 12/2018
5	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2022 - 12/2013
3	AntibodiesIBA 09/2023 - 01/2014
3	Alanine Transaminase (SGPT)IBA 06/2023 - 01/2014
3	Air Pollutants (Pollutants, Air)IBA 01/2023 - 01/2021
3	Hepatitis B e AntigensIBA 01/2021 - 01/2015
3	Immunoglobulins (Immunoglobulin)IBA 03/2020 - 08/2010
3	Immunoglobulin M (IgM)IBA 01/2019 - 12/2013
3	AntigensIBA 09/2015 - 12/2014
3	EnzymesIBA 01/2014 - 07/2009
2	COVID-19 VaccinesIBA 10/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 10/2023 - 09/2023
2	SolutionsIBA 06/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2014
2	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 01/2021 - 01/2009
2	Hepatitis B Core AntigensIBA 09/2015 - 07/2009
2	ImmunosorbentsIBA 01/2014 - 07/2009
2	hepatitis B hyperimmune globulinIBA 12/2013 - 12/2013
1	Polysaccharides (Glycans)IBA 04/2024
1	Conjugate VaccinesIBA 04/2024
1	A(2)C (A2C)IBA 03/2024
1	Combined VaccinesIBA 02/2024
1	Immunoglobulin A (IgA)IBA 10/2023
1	Hepatitis A AntibodiesIBA 09/2023
1	L 35 (L35)IBA 06/2023
1	Particulate MatterIBA 01/2023
1	Nitrogen DioxideIBA 01/2023
1	OzoneIBA 01/2023
1	Carbon MonoxideIBA 01/2023
1	ElementsIBA 11/2022
1	Carrier Proteins (Binding Protein)IBA 11/2022
1	Pyrethrins (Pyrethroids)FDA Link 07/2022
1	InsecticidesIBA 07/2022
1	Hemagglutinins (Hemagglutinin)IBA 03/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Tenofovir (Viread)FDA Link 06/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Surface Antigens (Surface Antigen)IBA 12/2014
1	Inactivated VaccinesIBA 01/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2013
1	Abscisic AcidIBA 11/2013

Therapy/Procedure

2	Therapeutics 10/2023 - 06/2023
1	Hand Hygiene 10/2020